Brazilian Registry of Menopausal Health
Official title: Population-based Cross-sectional Observational Study for a Brazilian Registry of Menopausal Women and Associated Factors Related to Clinical Profile, Socioeconomic Aspects, Social Disparities, Access to Healthcare, Quality of Life, and Knowledge About Menopause - EMBRACE Study (Endrocrine Mapping in the Broad Range Of Aging and Climateric Experiences)
Run by Science Valley Research Institute · NCT07005648 · Data updated 2026-11-12
This study tests how health, knowledge, and quality of life during menopause vary by region and socioeconomic factors in people aged 35 to 65 who are in the menopausal transition or postmenopause.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 35 Years to 65 Years |
| Sex | All |
| Enrollment | 1592 (estimated) |
| Sponsor | Science Valley Research Institute Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | September 11, 2026 |
| Main results expected | September 11, 2027 |
| Study ends | September 11, 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07005648 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 35–65 attending outpatient care in Brazil who are in the menopausal transition or postmenopause and able to provide informed consent.
✕Probably not a fit
Individuals outside the age range or unable to participate in an interview may not benefit from study findings for their personally tailored care.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
EMBRACE is a national, observational, cross-sectional study in Brazil that aims to describe epidemiological patterns and clinical profiles during the menopausal transition and postmenopause. It will enroll about 1,592 participants, including cisgender women and transgender men, across age strata and geographic locations, using a single interview, routine tests, and questionnaires collected during routine outpatient visits. A subset of 150 participants will receive additional non-invasive biometric assessments. The study will examine how socioeconomic conditions, access to care, social inequalities, quality of life, and knowledge about menopause relate to menopausal symptoms and clinical characteristics.
Why it matters
Potential benefit: Results could improve understanding of menopause-related health disparities and inform targeted public health strategies and patient education.
How similar studies have gone: Prior observational registry efforts in other populations have yielded useful insights into menopause-related health factors and disparities.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women aged between 35 and 65 years attending medical consultation at public and private outpatient health services; 2. Ability to confirm voluntary participation and sign the Informed Consent Form Exclusion Criteria: 1. Inability to respond to the interview for any reason 2. Suspected or confirmed pregnancy 3. Lactation 4. Uncontrolled diabetes 5. Uncontrolled arterial hypertension 6. Uncontrolled thyroid disorders 7. Grade 3 obesity, defined by a BMI equal to or greater than 40.0 kg/m² 8. Diagnosis of psychiatric disorders that may compromise participation in the interview 9. Previous hysterectomy 10. Previous oophorectomy 11. Current use of illicit drugs
Where it's running
-
Centro de Pesquisa Unidade Morumbi - Science Valley Research Institute
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Fabiane B de Souza, MD — Science Valley Research Institute
- Study coordinator: Leandro Agati
- Email: agati@svriglobal.com
- Phone: +55 (11) 4468-8183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Ashoka Bark and Shatavari for Menopause
This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
Pain and period life: does menstrual cycle or menopause change pain during root canals?
This study will see if pain during a root canal varies with menstrual cycle phase or menopausal status in adult patients.
-
Sex hormones, menopause, and exercise in aging women
This study tests how hormonal status and resistance training affect age-related muscle and nerve function in postmenopausal women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.